Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fcimb.2026.1749207.s008BackgroundSepsis is a life-threatening, heterogeneous syndrome with high mortality. This heterogeneity undermines current “one-size-fits-all” therapies and conventional biomarkers (e.g., PCT) lack prognostic power. A critical need exists to identify patient-specific endotypes and causal-driven therapeutic targets.MethodsWe employed a synergistic multi-omics strategy to identify causal drivers of sepsis. First, we used single-cell RNA sequencing (scRNA-seq) on peripheral blood mononuclear cells (GSE175453) to identify the most pathologically relevant immune cell subpopulation. Next, we used marker genes from this subset as exposures in a two-sample Mendelian randomization (MR) study, using summary statistics from a large-scale sepsis GWAS (11,643 cases/474,841 controls; ieu-b-4980) and eQTL data (eQTLGen) to validate causal relationships. Findings were explored via in-silico functional-genomics (GSEA, GSVA) and validated via qPCR in a clinical cohort (5 sepsis vs. 5 healthy controls).ResultsscRNA-seq analysis identified activated CD4+ T cells (Act.CD4T) as the cell subset contributing most significantly to sepsis pathogenesis. From 81 Act.CD4T marker genes, MR analysis identified four genes with a significant causal effect on sepsis risk: RPLP0 was identified as a causal risk factor (OR: 1.272; 95% CI: 1.031–1.569), while CD52 (OR: 0.903), RPS15A (OR: 0.954), and RPS18 (OR: 0.908) were identified as causal protective factors (all $pConclusionThis study is to integrate scRNA-seq and MR to discover cell-specific causal genes for sepsis. The identified four-gene signature provides potentially robust, causally-validated biomarkers for patient stratification and reveals the “Metabolism–Proteostasis–Immunity” axis as a critical, therapeutically-targetable node in sepsis pathogenesis.
Keyword(s):
activated CD4+ T cells; CD52; Clinical Microbiology; Mendelian randomization; RPLP0.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)